Literature DB >> 27349335

Transmitted/Founder HIV-1 Subtype C Viruses Show Distinctive Signature Patterns in Vif, Vpr, and Vpu That Are Under Subsequent Immune Pressure During Early Infection.

Raabya Rossenkhan1,2,3,4, Iain J MacLeod1,2, Zabrina L Brumme5,6, Craig A Magaret4, Theresa K Sebunya3, Rosemary Musonda1,2, Berhanu A Gashe3, Paul T Edlefsen4, Vlad Novitsky1,2, M Essex1,2.   

Abstract

Viral variants that predominate during early infection may exhibit constrained diversity compared with those found during chronic infection and could contain amino acid signature patterns that may enhance transmission, establish productive infection, and influence early events that modulate the infection course. We compared amino acid distributions in 17 patients recently infected with HIV-1C with patients with chronic infection. We found significantly lower entropy in inferred transmitted/founder (t/f) compared with chronic viruses and identified signature patterns in Vif and Vpr from inferred t/f viruses. We investigated sequence evolution longitudinally up to 500 days postseroconversion and compared the impact of selected substitutions on predicted human leukocyte antigen (HLA) binding affinities of published and predicted cytotoxic T-lymphocyte epitopes. Polymorphisms in Vif and Vpr during early infection occurred more frequently at epitope-HLA anchor residues and significantly decreased predicted epitope-HLA binding. Transmission-associated sequence signatures may have implications for novel strategies to prevent HIV-1 transmission.

Entities:  

Keywords:  CTL epitope; HIV transmission; Vif; Vpr; Vpu; accessory genes; evolution

Mesh:

Substances:

Year:  2016        PMID: 27349335      PMCID: PMC5067802          DOI: 10.1089/AID.2015.0330

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  65 in total

1.  Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.

Authors:  Bin Yang; Ling Gao; Lin Li; Zhixian Lu; Xuejun Fan; Charvi A Patel; Roger J Pomerantz; Garrett C DuBois; Hui Zhang
Journal:  J Biol Chem       Date:  2002-12-11       Impact factor: 5.157

2.  Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+ T cell responses.

Authors:  S I Bazhan; L I Karpenko; T N Ilyicheva; P A Belavin; S V Seregin; N K Danilyuk; D V Antonets; A A Ilyichev
Journal:  Mol Immunol       Date:  2010-02-26       Impact factor: 4.407

3.  HIV quasispecies and resampling.

Authors:  S L Liu; A G Rodrigo; R Shankarappa; G H Learn; L Hsu; O Davidov; L P Zhao; J I Mullins
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

4.  Characterization and phylogenetic analysis of South African HIV-1 subtype C accessory genes.

Authors:  T J Scriba; F K Treurnicht; M Zeier; S Engelbrecht; E J van Rensburg
Journal:  AIDS Res Hum Retroviruses       Date:  2001-05-20       Impact factor: 2.205

Review 5.  Bottlenecks in HIV-1 transmission: insights from the study of founder viruses.

Authors:  Sarah B Joseph; Ronald Swanstrom; Angela D M Kashuba; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2015-06-08       Impact factor: 60.633

6.  Identification of primary HIV-1C infection in Botswana.

Authors:  V Novitsky; E Woldegabriel; C Wester; E McDonald; R Rossenkhan; M Ketunuti; J Makhema; G R Seage; M Essex
Journal:  AIDS Care       Date:  2008-08

7.  HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Authors:  B D Walker; S Chakrabarti; B Moss; T J Paradis; T Flynn; A G Durno; R S Blumberg; J C Kaplan; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1987 Jul 23-29       Impact factor: 49.962

8.  Viral diversity and diversification of major non-structural genes vif, vpr, vpu, tat exon 1 and rev exon 1 during primary HIV-1 subtype C infection.

Authors:  Raabya Rossenkhan; Vladimir Novitsky; Theresa K Sebunya; Rosemary Musonda; Berhanu A Gashe; M Essex
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

Review 9.  HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention.

Authors:  Michael Kogan; Jay Rappaport
Journal:  Retrovirology       Date:  2011-04-13       Impact factor: 4.602

10.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors:  Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

View more
  2 in total

1.  Genome-wide association study reveals genetic variants associated with HIV-1C infection in a Botswana study population.

Authors:  Andrey K Shevchenko; Daria V Zhernakova; Sergey V Malov; Alexey Komissarov; Sofia M Kolchanova; Gaik Tamazian; Alexey Antonik; Nikolay Cherkasov; Sergey Kliver; Anastasiia Turenko; Mikhail Rotkevich; Igor Evsyukov; David Vlahov; Prisca K Thami; Simani Gaseitsiwe; Vladimir Novitsky; Myron Essex; Stephen J O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 12.779

2.  HIV-1 Vpr antagonizes innate immune activation by targeting karyopherin-mediated NF-κB/IRF3 nuclear transport.

Authors:  Hataf Khan; Rebecca P Sumner; Jane Rasaiyaah; Choon Ping Tan; Maria Teresa Rodriguez-Plata; Chris Van Tulleken; Douglas Fink; Lorena Zuliani-Alvarez; Lucy Thorne; David Stirling; Richard Sb Milne; Greg J Towers
Journal:  Elife       Date:  2020-12-10       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.